Global Parkinsons Disease Drug Market Research Report 2016

September 2016 | 114 pages | ID: G19FDDDD1BCEN
QYResearch

Abstracts

Notes:

Production, means the output of Parkinsons Disease Drug

Revenue, means the sales value of Parkinsons Disease Drug

This report studies Parkinsons Disease Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Merck
• Akorn
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Kyowa Hakko Kirin Pharma
• Orion
• Stada Arzneimittel
• Valeant
• Apokyn

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Parkinsons Disease Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Parkinsons Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Parkinsons Disease Drug Market Research Report 2016

1 PARKINSONS DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Parkinsons Disease Drug Segment by Type
  1.2.1 Global Production Market Share of Parkinsons Disease Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Parkinsons Disease Drug Segment by Application
  1.3.1 Parkinsons Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Parkinsons Disease Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Parkinsons Disease Drug (2011-2021)

2 GLOBAL PARKINSONS DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Parkinsons Disease Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Parkinsons Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Parkinsons Disease Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Parkinsons Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Parkinsons Disease Drug Market Competitive Situation and Trends
  2.5.1 Parkinsons Disease Drug Market Concentration Rate
  2.5.2 Parkinsons Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PARKINSONS DISEASE DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Parkinsons Disease Drug Production by Region (2011-2016)
3.2 Global Parkinsons Disease Drug Production Market Share by Region (2011-2016)
3.3 Global Parkinsons Disease Drug Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PARKINSONS DISEASE DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Parkinsons Disease Drug Consumption by Regions (2011-2016)
4.2 North America Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Parkinsons Disease Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PARKINSONS DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Parkinsons Disease Drug Production and Market Share by Type (2011-2016)
5.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Parkinsons Disease Drug Price by Type (2011-2016)
5.4 Global Parkinsons Disease Drug Production Growth by Type (2011-2016)

6 GLOBAL PARKINSONS DISEASE DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Parkinsons Disease Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PARKINSONS DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 GSK
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 GSK Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Novartis
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Novartis Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Boehringer Ingelheim Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Teva Pharmaceutical
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Teva Pharmaceutical Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Abbvie
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Abbvie Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Merck
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Akorn
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Akorn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Astellas Pharma
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Astellas Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Desitin Arzneimittel
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Desitin Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Endo Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Parkinsons Disease Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Endo Pharmaceuticals Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 F.Hoffmann-La Roche
7.12 H.Lundbeck
7.13 Kyowa Hakko Kirin Pharma
7.14 Orion
7.15 Stada Arzneimittel
7.16 Valeant
7.17 Apokyn

8 PARKINSONS DISEASE DRUG MANUFACTURING COST ANALYSIS

8.1 Parkinsons Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Parkinsons Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Parkinsons Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PARKINSONS DISEASE DRUG MARKET FORECAST (2016-2021)

12.1 Global Parkinsons Disease Drug Production, Revenue Forecast (2016-2021)
12.2 Global Parkinsons Disease Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Parkinsons Disease Drug Production Forecast by Type (2016-2021)
12.4 Global Parkinsons Disease Drug Consumption Forecast by Application (2016-2021)
12.5 Parkinsons Disease Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons Disease Drug
Figure Global Production Market Share of Parkinsons Disease Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Parkinsons Disease Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Parkinsons Disease Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Parkinsons Disease Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Parkinsons Disease Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Parkinsons Disease Drug Capacity of Key Manufacturers in 2015
Figure Global Parkinsons Disease Drug Capacity of Key Manufacturers in 2016
Table Global Parkinsons Disease Drug Production of Key Manufacturers (2015 and 2016)
Table Global Parkinsons Disease Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinsons Disease Drug Production Share by Manufacturers
Figure 2016 Parkinsons Disease Drug Production Share by Manufacturers
Table Global Parkinsons Disease Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Parkinsons Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Parkinsons Disease Drug Revenue Share by Manufacturers
Table 2016 Global Parkinsons Disease Drug Revenue Share by Manufacturers
Table Global Market Parkinsons Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Parkinsons Disease Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Parkinsons Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Parkinsons Disease Drug Product Type
Figure Parkinsons Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinsons Disease Drug Market Share of Top 5 Manufacturers
Table Global Parkinsons Disease Drug Capacity by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Capacity Market Share by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Parkinsons Disease Drug Capacity Market Share by Regions
Table Global Parkinsons Disease Drug Production by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Production and Market Share by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Parkinsons Disease Drug Production Market Share by Regions
Table Global Parkinsons Disease Drug Revenue by Regions (2011-2016)
Table Global Parkinsons Disease Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Parkinsons Disease Drug Revenue Market Share by Regions
Table Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Parkinsons Disease Drug Consumption Market by Regions (2011-2016)
Table Global Parkinsons Disease Drug Consumption Market Share by Regions (2011-2016)
Figure Global Parkinsons Disease Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Parkinsons Disease Drug Consumption Market Share by Regions
Table North America Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table China Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table India Parkinsons Disease Drug Production, Consumption, Import & Export (2011-2016)
Table Global Parkinsons Disease Drug Production by Type (2011-2016)
Table Global Parkinsons Disease Drug Production Share by Type (2011-2016)
Figure Production Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure 2015 Production Market Share of Parkinsons Disease Drug by Type
Table Global Parkinsons Disease Drug Revenue by Type (2011-2016)
Table Global Parkinsons Disease Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Parkinsons Disease Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Parkinsons Disease Drug by Type
Table Global Parkinsons Disease Drug Price by Type (2011-2016)
Figure Global Parkinsons Disease Drug Production Growth by Type (2011-2016)
Table Global Parkinsons Disease Drug Consumption by Application (2011-2016)
Table Global Parkinsons Disease Drug Consumption Market Share by Application (2011-2016)
Figure Global Parkinsons Disease Drug Consumption Market Share by Application in 2015
Table Global Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Parkinsons Disease Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Parkinsons Disease Drug Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Parkinsons Disease Drug Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Parkinsons Disease Drug Market Share (2011-2016)
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Parkinsons Disease Drug Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Parkinsons Disease Drug Market Share (2011-2016)
Table Akorn Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akorn Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Akorn Parkinsons Disease Drug Market Share (2011-2016)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Parkinsons Disease Drug Market Share (2011-2016)
Table Desitin Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Desitin Arzneimittel Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Desitin Arzneimittel Parkinsons Disease Drug Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo Pharmaceuticals Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Endo Pharmaceuticals Parkinsons Disease Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drug
Figure Manufacturing Process Analysis of Parkinsons Disease Drug
Figure Parkinsons Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinsons Disease Drug
Table Distributors/Traders List
Figure Global Parkinsons Disease Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Parkinsons Disease Drug Production Forecast by Regions (2016-2021)
Table Global Parkinsons Disease Drug Consumption Forecast by Regions (2016-2021)
Table Global Parkinsons Disease Drug Production Forecast by Type (2016-2021)
Table Global Parkinsons Disease Drug Consumption Forecast by Application (2016-2021)